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Abstract
AIM
To undertook a systematic review to determine factors 
that increase a patient’s risk of developing lower limb 
periprosthetic joint infections (PJI).
 
METHODS
This systematic review included full-text studies that 
reviewed risk factors of developing either a hip or knee PJI 
following a primary arthroplasty published from January 
1998 to November 2016. A variety of keywords were 
used to identify studies through international databases 
referencing hip arthroplasty, knee arthroplasty, infection, 
and risk factors. Studies were only included if they included 
greater than 20 patients in their study cohort, and there 
was clear documentation of the statistical parameter used; 
specifically P-value, hazard ratio, relative risk, or/and odds 
ratio (OR). Furthermore a quality assessment criteria for 
the individual studies was undertaken to evaluate the 
presence of record and reporting bias. 
RESULTS
Twenty-seven original studies reviewing risk factors 
relating to primary total hip and knee arthroplasty 
infections were included. Four studies (14.8%) reviewed 
PJI of the hip, 3 (11.21%) of the knee, and 20 (74.1%) 
reviewed both joints. Nineteen studies (70.4%) were 
retrospective and 8 (29.6%) prospective. Record bias 
was identified in the majority of studies (66.7%). The 
definition of PJI varied amongst the studies but there 
was a general consensus to define infection by previously 
validated methods. The most significant risks were the use 
of preoperative high dose steroids (OR = 21.0, 95%CI: 
3.5-127.2, P < 0.001), a BMI above 50 (OR = 18.3, P < 
0.001), tobacco use (OR = 12.76, 95%CI: 2.47-66.16, P 
Submit a Manuscript: http://www.f6publishing.com
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= 0.017), body mass index below 20 (OR = 6.00, 95%CI: 
1.2-30.9, P  = 0.033), diabetes (OR = 5.47, 95%CI: 
1.77-16.97, P = 0.003), and coronary artery disease (OR 
= 5.10, 95%CI: 1.3-19.8, P = 0.017).
CONCLUSION
We have highlighted the need for the provider to op-
timise modifiable risk factors, and develop strategies to 
limit the impact of non-modifiable factors.
Key words: Periprosthetic joint infection; Risk factor; 
Predictive; Hip arthroplasty; Knee arthroplasty
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: This systematic review determines the most 
statistically significant factors that increase a patient’s risk 
of developing lower limb periprosthetic joint infections. 
Reviewing all relevant papers until November 2016 through 
international databases, we have included 27 original 
studies. The results include multiple factors relating to 
the patient and the Institute, as well as post-operative 
predictors and causes of infection. This ultimately reiterates 
the importance of optimising the patients pre-operatively 
by addressing modifiable risk factors (such as their 
immunosuppression, nutrition, diabetes, and smoking), and 
develops strategies to limit the impact of non-modifiable 
factors.
George DA, Drago L, Scarponi S, Gallazzi E, Haddad FS, Romano 
CL. Predicting lower limb periprosthetic joint infections: A review 
of risk factors and their classification. World J Orthop 2017; 8(5): 
400­411  Available from: URL: http://www.wjgnet.com/2218­5836/
full/v8/i5/400.htm  DOI: http://dx.doi.org/10.5312/wjo.v8.i5.400
IntroductIon
Chronic periprosthetic joint infections (PJI) have received 
increasing interest in the medical literature as the pro­
fession has acknowledged the real­life implications to 
the patient and the health service[1,2]. The treatment of 
PJI is costly to the health service with strain upon limited 
resources as multiple operations and trials of antibiotic 
therapy may be attempted. But the cost to the patient is 
greatest, with loss or reduced joint function, deterioration 
in their physical and psychological health, and loss in 
trust with the profession.
Prevention is key. Despite improved outcomes following 
the various treatment modalities for treating established 
infections today, the patient has to endure the con­
sequences of the infection[3]. Prior to the initial surgery it 
is imperative the patient is medically optimised and any 
reversible risk factors be corrected. Such risk factors are 
well known such as diabetes[4], systemic infections[5], and 
immunocompromise[6]. 
However, risk factors vary and are dependent upon 
the patient cohort, and often findings from isolated 
studies are not transferable. Therefore, we undertook 
a systematic review of the literature to determine over­
all predictive factors that increase a patient’s risk of 
developing a lower limb PJI, and determine which risk 
factors are most predictive of infection.
In this review, we categorised risk factors in order 
to better understand the relative role of the host, of the 
healthcare provider, and of post­surgical conditions, the 
latter acting more as prognostic factors since the surgical 
procedure has already taken place. To this aim, we have 
subdivided known risk factors for PJI in three groups: (1) 
those relating to the host (host­related risk factors); (2) 
those that are related to the treatment provider and to 
the surgical environment (provider­related risk factors); 
and (3) those that arise from clinical interventions, 
increasing the patient’s inherent risk (post­surgical risk 
factors). We have then compared the absolute number of 
risk factors in each main category, scored them according 
to their relative weight and divided in “modifiable” and 
“non-modifiable” risk factors.
MAtErIALS And MEthodS 
This systematic review included full­text studies that 
reviewed risk factors of developing either a hip or knee PJI 
following a primary arthroplasty published from January 
1998 to November 2016. These were identified through 
international databases, such as EMBASE, PubMed/
MEDLINE, MEDLINE Daily Update, MEDLINE In­Process, 
Google Scholar, SCOPUS, CINAHL, Cochrane Central 
Register of Controlled Trials and Cochrane Database of 
Systematic Reviews. 
A variety of keywords were used either alone or in 
combinations to identify the studies. This included re­
ferences to hip infections (total hip replacement; THR; 
periprosthetic hip infection, hip arthroplasty infection), knee 
infections (total knee replacement; TKR; periprosthetic 
knee infection, knee arthroplasty infection), general joint 
infections (PJI, PPI), and “risk factors”. We did not use 
specific keywords to search for individual risk factors, such 
as diabetes, etc. 
Studies were only included if the risk factors were 
calculated by involving greater than 20 patients in their 
study cohort, and there was clear documentation of the 
statistical parameter used, and were only included if the 
P­value was quoted and one or more of the following; 
hazard ratio (HR), relative risk (RR), or/and odds ratio. 
Studies were excluded if they referred to recurrent infection 
following a revision procedure, hip or knee fracture, and a 
risk factor was excluded if the p­value was greater than 0.05. 
Results from combined studies, as seen in meta­analysis, 
were also excluded.
Two investigators, DAG and CLR, independently se­
arched and reviewed the literature and determined if the 
study should be included based on their title and abstract. 
Once the two lists were compared, if the same material 
was presented in more than one study, only the most 
recent one was included. 
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The quality assessment criteria for the inclusion of 
the individual studies was adapted from George et al[7]. 
to reflect the information we expect to be present in 
each study. Therefore we evaluated the presence of (1) 
record bias reflecting the source of data, and whether 
the analysis was retrospective or prospective; and 
(2) reporting bias; each study’s definition of PJI (the 
measured outcome). 
Figure 1 demonstrates the overall selection process 
according to the Prisma model[8]. DAG, CLR, SS and EG 
compared the overall findings and any discrepancies 
were solved by reclassification as mutually agreed. 
rESuLtS
Included studies
In all, 27 original studies reviewing risk factors relating 
to primary total hip and knee arthroplasty infections 
were included. The number of risk factors identified 
ranged from 1 to 18. Four studies (14.8%) reviewed PJI 
on the hip, 3 (11.21%) on the knee, and 20 (74.1%) 
reviewed both joints. The statistical methods used to 
determine significance are also shown in Table 1[4,5,9­33].
The quality of the included studies is demonstrated 
in Table 2. Nineteen studies (70.4%) were retrospective 
Potentially relevant studies identified and 
screened for retrieval = 95
Full text articles assessed for eligibility = 41
Total number of included studies = 27
Studies excluded secondary to
  Title or abstract = 54
Studies excluded secondary to
  Number of patients (n  = 3)
  Absent p-value and OR/HR/RR (n  = 8)
  Joint involvement unclear (n  = 3)
Figure 1  Flowchart summarizing the results of 
the literature search. RR: Relative risk; HR: Hazard 
ratio; OR: Odds ratio.
Table 1  Study characteristics including number of patients, statistical method used, site (hip, knee or both), and duration of patient follow-up
Ref. Year Patients (n ) Statistical 
method used
Site Follow-up (mo)
Infected (cases) Non-infected (controls) Total Min Max Mean
Berbari et al[9] 1998   462        462       924 OR, CI, P Both - - -
Lai et al[10] 2007     51 - - OR, CI, P Both - 84 -
Parvizi et al[11] 2007     78       156       234 OR, CI, P Both - - -
Pulido et al[12] 2008     63     9182     9245 HR, CI, P Both 12 72 43
Malinzak et al[13] 2009     43      8451     8494 OR, P Both 24 192 74.4
Ong et al[14] 2009   887    39042   39929 OR, P Hip - 108 -
Berbari et al[5] 2010   339        339       678 OR, CI, P Both - - -
Peel et al[15] 2011     63        126       189 OR, CI, P Both - - -
Bozic et al[16] 2012 - -   40919 HR, CI, P Hip 12 - -
Jämsen et al[17] 2012     52      7129     7181 HR, CI, P Both 0 12 12
Bozic et al[4] 2012 - -   83011 OR, CI, P Knee 12 - -
Dale et al[18] 2012 2778 429390 432168 RR, CI, P Hip 0 60 60
Greenky et al[19] 2012  389   15333   15722 OR, CI, P Both 36 108 62.4
Namba et al[20] 2013  404   55812   56216 HR, CI, P Knee - - -
Somayaji et al[21] 2013       5        254       259 OR, CI, P Both 12 124 24
Coelho-Prabhu et al[22] 2013   339        339       678 OR, CI, P Both 2 24 -
Maoz et al[23] 2014     47     3625     3672 OR, CI, P Hip 12 48 24
Gómez-Lesmes et al[24] 2014     32     1299     1331 OR, CI, P Knee - 3 -
Yi et al[25] 2014   126        375       501 OR, CI, P Both 3 - -
Wu et al[26] 2014     45        252       297 OR, CI, P Both 12 144 28
Sousa et al[27] 2014     43     2454     2497 OR, CI, P Both 1 12 12
Jiang et al[28] 2014 - - 306946 HR, P Hip 6 - -
2014 - - 573840 HR, P Knee 6 - -
Duchman et al[29] 2015    8062+      70129+   78191 OR, CI, P Both - - -
Chrastil et al[30] 2015 - -   13272 HR, CI, P Both 24 120 -
Crowe et al[31] 2015     26      3393     3419 OR, CI, P Both - 12 -
Debreuve-Theresette et al[32] 2015     45          90 OR, CI, P Both - - -
Bohl et al[33] 2015 - -   49603 RR, CI, P Both - 1 -
George DA et al . Lower limb PJI risk factors
RR: Relative risk; HR: Hazard ratio; OR: Odds ratio.
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and 8 (29.6%) prospective. Record bias was identified 
in the majority of studies (66.7%). The definition of 
PJI varied amongst the studies but there was a general 
consensus to define infection by previously validated 
methods. 
This included the presence of 2 or more cultural positive 
results for the same microorganism (plus other features 
on infection) in 4 studies (14.8%), the CDC definition 
in 5 studies (18.5%), the Medicare code for infection 
in 5 studies (18.5%), and 9 studies (33.3%) based 
their definition on patients meeting 3 of the following 5 
features; (1) abnormal serology (ESR > 30 mm/h; CRP > 
1 mg/dL); (2) strong clinical and radiographic suspicion for 
infection; (3) positive joint aspiration culture for infection; 
(4) evidence of purulence during the subsequent surgical 
intervention; and (5) positive intraoperative culture.
One study used the MSIS criteria, which includes: 
(1) a sinus tract; (2) positive culture results from 2 or 
more tissue or fluid samples; and (3) 4 of the following 
6 criteria are present: (Ⅰ) elevated CRP/ESR; (Ⅱ) 
elevated synovial WCC; (Ⅲ) high synovial PMN leukocyte 
percentage; (Ⅳ) presence of purulence in the joint; (Ⅴ) 
positive culture result from one sample from the affected 
joint; and (Ⅵ) PMN leukocyte count of more than 5 per 
high-powered field in 5 high-powered fields on histologic 
analysis at 400 × magnification[34].
Host-related risk factors
Risk factors relating to the host have been shown in Table 3, 
and are the most abundant group of risk factors identified. The 
majority of the risk factors are systemic referring to patient 
co­morbidities that are negatively associated with patient 
outcome following a primary THR or TKR, such as presence 
of diabetes mellitus[4,9,17,20,26], immunocompromised[5,15,21], 
concomitttent systemic infection[5,10,27,31], cardiology[4,16,21] 
and gastroenterology disorders[22,28], high ASA (American 
Society of Anesthesiologists) grade[12,15,20] and mal­
nutrition[13,17,21,23,25,26,33].
Patient demographics also have been shown to have an 
impact upon risk of PJI, including age[16], rural residence[16], 
race[20], male gender[14,18,20,31], and alcohol[26] or tobacco 
use[23,29,31,32]. Previous operations to the joint (excluding 
revisions arthroplasty as this was excluded from analysis) 
increased the risk of PJI[5,32].
Table 2  Paper quality, defined by presence of record and reporting bias
Ref. Design Record bias Reporting bias (outcome measure); definition of infection
Berbari et al[9] Retrospective No 2 or more cultural examination positive for the same microorganism; sinus tract; 
purulence around the prosthesis/joint
Lai et al[10] Retrospective No 2 or more cultural examination positive for the same microorganism; clinical 
diagnosis
Parvizi et al[11] Prospective No Criteria based upon 3 of 5 features1
Pulido et al[12] Retrospective Yes Criteria based upon 3 of 5 features1
Malinzak et al[13] Retrospective No Unknown
Ong et al[14] Retrospective Yes Diagnostic code in Medicare database
Berbari et al[5] Prospective Yes 2 or more cultural examination positive for the same microorganism; acute 
inflammation on histopathological examination; sinus tract; purulence around the 
prosthesis/joint
Peel et al[15] Prospective Yes Criteria based upon 3 of 5 features1
Bozic et al[16] Retrospective Yes Diagnostic code in Medicare database
Jämsen et al[17] Prospective Yes CDC definition of surgical site infection3
1Bozic et al[4] Retrospective Yes Diagnostic code in Medicare database
Dale et al[18] Retrospective Yes Clinical as reported by the surgeon after surgery
Greenky et al[19] Retrospective No Criteria based upon 3 of 5 features1
Namba et al[20] Retrospective Yes CDC definition of surgical site infection3
Somayaji et al[21] Retrospective No Criteria based upon 3 of 5 features1
Coelho-Prabhu et al[22] Retrospective Yes 2 or more cultural examination positive for the same microorganism; sinus tract; 
purulence around the prosthesis/joint
Maoz et al[23] Retrospective Yes CDC definition of surgical site infection3
Gómez-Lesmes et al[24] Prospective Yes Criteria based upon 3 of 5 features1
Yi et al[25] Retrospective No Criteria based upon 3 of 5 features1
Wu et al[26] Retrospective Yes MSIS definition2
Sousa et al[27] Retrospective No Criteria based upon 3 of 5 features1
Jiang et al[28] Prospective Yes Diagnostic code in Medicare database
Duchman et al[29] Prospective Yes Criteria based upon 3 of 5 features1
Chrastil et al[30] Retrospective Yes Diagnostic code in Medicare database
Crowe et al[31] Retrospective Yes CDC definition of surgical site infection3
Debreuve-Theresette et al[32] Retrospective No CDC definition of surgical site infection3
Bohl et al[33] Prospective Yes American College of Surgeons National Surgical Quality Improvement Program 
definition
1Refers to 3 of 5 of the following criteria: (1) abnormal serology (ESR > 30 mm/h; CRP > 1 mg/dL); (2) strong clinical and radiographic suspicion for 
infection; (3) positive joint aspiration culture for infection; (4) evidence of purulence during the subsequent surgical intervention; and (5) positive 
intraoperative culture; 2Musculoskeletal Infection Society (MSIS) definition; 3Defined as (1) deep infection; (2) purulent drainage; (3) dehiscence; (4) fever; 
and (5) localized pain. CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate.
George DA et al . Lower limb PJI risk factors
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Table 3  Host-related risk factors
Ref. Statistical parameter Site
HR OR RR 95%CI P  value
General
  Age: 65-75 yr (compared to 45-65) [26]      3.36 1.30-8.69    0.013 Hip/knee
  Comorbidities (total number) [10]      1.35 1.10-1.66    0.005 Hip/knee
  Charlson index + 5 (compared to 0) [14]      2.57 1.96-3.37 < 0.001 Hip
  Place of residence (rural) [26]      2.63 1.13-6.10    0.025 Hip/knee
  Hispanic race (compared to White) [20]   0.69 0.49-0.98    0.038 Knee
  Alcohol abuse [26]      2.95 1.06-8.23    0.039 Hip/knee
  Tobacco use [29]      1.47 1.21-1.78    0.001 Hip/knee
[31]    3.4 1.23-9.44    0.029 Hip/knee
[32]   3.91    3.4   1.19-12.84    0.032 Hip/knee
  Tobacco use (S aureus colonization) [23]     12.76   2.47-66.16    0.017 Hip
Gender
  Female [14]       0.83    0.009 Hip
  Male [18] 1.9 1.80-2.10 < 0.001 Hip
[20]   1.89 1.54-2.32 < 0.001 Knee
[31]       3.55 1.60-7.84    0.002
Endocrine  disorders
  Diabetes mellitus [4]       1.19 1.06-1.34       0.0025 Knee
[26]      5.47   1.77-16.97    0.003 Hip/knee
[22]   1.46 1.27-1.68      0.0007 Hip
[9] 4   1.13-14.18    0.032 Hip/knee
[20]   1.28 1.03-1.60    0.025 Knee
[17]   2.31 1.12-4.72 < 0.001 Hip/knee
[15]    1.4 0.90-2.10  0.06 Hip/knee
[5]    1.8 1.20-2.80    0.006 Hip/knee
[13]    3.1   0.02 Hip/knee
[44]      2.21 1.34-3.64    0.001 Knee
  Pre-op BM > 6.9 mmol/L [17]   2.25 0.60-8.50    0.073 Hip/knee
  Pre-operative hyperglycemia [30]   1.44 1.09-1.89    0.008 Hip/knee
Psychiatric disorders
  Depression [4]      1.28 1.08-1.51       0.0035 Knee
[16] 1.6 1.32-1.93       0.0039 Hip
  Psychosis [16]   1.74 1.38-2.20       0.0044 Hip
[4]      1.26 1.02-1.57       0.0331 Knee
Haematological disorders
  Preoperative anaemia [16]   1.36 1.15-1.62       0.0005 Hip
[19]      1.95 1.41-2.69 < 0.001 Hip/knee
[4]      1.26 1.09-1.45       0.0014 Knee
  Coagulopathy [16]   1.58 1.24-2.01       0.0002 Hip
Malignancy
  Metastatic malignancy [4]      1.59 1.03-2.47       0.0369 Knee
  Tumour 5 yr before implant [5]   3.1 1.30-7.20 < 0.01 Hip/knee
Cardiovascular disorders
  Congestive heart failure [4]      1.28 1.13-1.46   < 0.0001 Knee
[16]   1.57 1.33-1.84      0.0409 Hip
  Cardiac arrhythmia [16]   1.48 1.30-1.70      0.0012 Hip
  Coronary artery disease [21]      5.10 1.30-19.8    0.017 Hip/knee
  Valvular disease [4]      1.15 1.01-1.31    0.039 Knee
  Peripheral vascular disease [4]      1.13 1.01-1.27      0.0381 Knee
[16]   1.44 1.24-1.68      0.0032 Hip
Gastroenterology disorders
  Liver cirrhosis [28] 5.4 < 0.001 Hip
[28] 3.4 < 0.001 Knee
  Hepatitis B virus (amongst males) [44]      4.32   1.85-10.09 < 0.001 Knee
  OGD with biopsy [22]    2.8 1.10-7.10   0.03 Hip/knee
Respiratory disorders
  Chronic pulmonary disease [4]      1.22 1.10-1.36   < 0.0001 Knee
[31]      4.34   1.28-14.70    0.041 Both
  Pulmonary circulation disorders [4]      1.42 1.06-1.91      0.0205 Knee
Renal disorders
  Renal disease [4]      1.38 1.11-1.71      0.0038 Knee
  Renal function (mL/min) [15] 1 0.90-1.00  0.05 Hip
Rheumatoid arthritis
  Rheumatoid arthritis [15]    3.3   0.80-13.90   0.09 Hip/knee
[4]      1.18 1.02-1.37       0.0277 Knee
[16]   1.71 1.42-2.06   < 0.0001 Hip
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Provider-related risk factors
Risk factors relating to the provider are shown in Table 4. 
Prolonged operative duration of greater than 115 minutes 
in hip arthroplasty is a strong predictor of infection[5,14,23], 
as is non­same day surgery[23]. During knee arthroplasty, 
exposure to the joint requiring quadriceps release signi­
ficantly increases the risks of infection[20].
Protective measures include the use of antibiotic surgical 
prophylaxis systemically[5] and locally as irrigation[20], 
but antibiotic impregnated cement may or may not be 
protective[18,20]. In addition, bilateral procedures during 
the same operation have been shown by some studies to 
increase the risk[12], whilst in others decrease it[20].
Post-surgical risk factors
Post­operatively patients may present with a superficial 
infection to the joint with a warm, cellulitic, and sometimes 
discharging wound, which is a high predictor of an under­
lying PJI[5,11,9,15]. Table 5 demonstrates other factors that 
have a high correlation with a PJI, including receiving a 
blood transfusion[11,12,15] (especially if the blood has been 
stored for greater than 14 d[24]), post­operative urinary tract 
infection (UTI)[5,12], and onset of cardiac arrhythmias[12].
Risk factor impact
Several risk factors were shown to have greater signi­
ficance than others, and a vast majority of the risk 
factors were directly related to the patient (host­factors). 
The most significant risks were the use of preoperative 
high dose steroids (OR = 21.0, 95%CI: 3.5­127.2, p < 
0.001)[21], a BMI above 50 (OR = 18.3, p < 0.001)[13], 
tobacco use (OR = 12.76, 95%CI: 2.47­66.16, p = 
0.017)[23], BMI below 20 (OR = 6.00, 95%CI: 1.2­30.9, 
p = 0.033)[21], diabetes (OR = 5.47, 95%CI: 1.77­16.97, 
p = 0.003)[26], and coronary artery disease (OR = 5.10, 
95%CI: 1.3­19.8, p = 0.017)[21].
Modifiable risk factors
We further categorised the resultant risk factors into 
whether or not they were modifiable, reflecting the 
opportunity of the surgeon to optimise their patient pre­
operatively and to reduce the risk of developing a PJI 
(Table 6).
dIScuSSIon
It is extremely difficult to predict if a patient will develop a 
ASA grade
  ASA score [15]   2.2 1.30-4.00    0.006 Hip/knee
  Mean score [11]   2.07 1.08-1.97    0.03 Hip/knee
  3 (compared to 1 or 2) [20] 1.65 1.33-2.00 < 0.001 Knee
  > 4 [12] 1.95 1.00-3.70    0.04 Hip/knee
Body mass index
  Obesity [4]   1.22 1.03-1.44    0.0219 Knee
[16] 1.73   1.35-2.22 < 0.0001 Hip
  BMI (kg/m2) [15]   1.1 1.00-1.10    0.05 Hip
[12] 3.23 1.60-6.50    0.001 Hip/knee
     < 20 [21]   6 1.20-30.9    0.033 Hip/knee
     25-30 [5]   0.4 0.30-0.70 < 0.001 Hip/knee
     ≥ 28 (compared to 18.5-28) [26]   2.77 1.20-6.40    0.017 Hip/knee
     31-39 [5]   0.5 0.30-0.70 < 0.001 Hip/knee
     35 (compared to < 35) [20] 1.47 1.17-1.85    0.001 Knee
[32] 1.84 1.11-3.05    0.007 Both
     > 40 [23]   4.13 1.30-12.88    0.01 Hip
[13]   3.3    0.045 Knee
[17] 6.41 1.67-24.59 < 0.001 Hip/knee
     > 50 [13] 18.3 < 0.001 Hip/knee
  Malnutrition [25]   2.3 1.50-3.50 < 0.001 Hip/knee
  Serum albumin < 3.5 g/dL [33]   2 1.50-2.80 < 0.001 Hip/knee
Immunocompromise
  Immunocompromise [5]   2.2 1.60-3.00 < 0.001 Hip/knee
  Inflammatory disease [18] 1.4 1.10-1.70    0.001 Hip
  Prednisone dose exceeds 15 mg/d [21] 21 3.50-127.2 < 0.001 Hip/knee
  Systemic steroid therapy [15]   3.3 0.80-13.90    0.09 Hip/knee
Infection
  Distant organ infection [5]   2.2 1.50-3.25 < 0.001 Hip/knee
  Nasal S. Aureus Infection [31]   3.95 1.80-8.71 < 0.001 Hip/knee
  Nasal MRSA Infection [31]   8.24 3.23-21.02 < 0.001 Hip/knee
  Asymptomatic bacteriuria [27]   3.23 1.67-6.27    0.001 Hip/knee
  Genitourinary infection [10]   2.8 1.01-7.77    0.048 Hip/knee
Operative indication
  Hip fracture [18] 2.1 1.90-2.40 < 0.001 Hip
  Post-traumatic osteoarthritis [20] 3.23 1.68-6.23 < 0.001 Knee
  Prior operation on the index joint [5]   1.9 1.30-2.60 < 0.001 Hip/knee
  Per additional surgery [32]   2.88 1.45-5.80    0.018 Hip/knee
  Avascular necrosis [18] 1.7 1.40-2.10 < 0.001 Hip
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Table 4  Provider-related risk factors
Ref. Statistical parameter Site
HR OR RR 95%CI P  value
Antibiotic use
  Antibiotic surgical prophylaxis [5] 0.5 0.30-0.80 0.003 Hip/knee
  Antibiotic irrigation [20] 0.67 0.48-0.92 0.014 Knee
Surgical technique
  Exposure requiring quadriceps release [20] 4.76 1.18-19.21 0.029 Knee
  Use of wound drain tube [15] 0.09 0.01-0.80 0.03 Knee
Side of surgery
  Simultaneous bilateral surgery [12] 5.85 2.50-13.90 < 0.0001 Hip/knee
[20] 0.51 0.31-0.83 0.007 Knee
  Single side (compared to bilateral) [13] 3.1 0.0024 Hip/knee
[13] 4 0.009 Knee
Cement
  Antibiotic-laden cement  [20] 1.53 1.18-1.98 < 0.001 Knee
  Non-antibiotic cement [8] 1.5 1.30-1.80 < 0.001 Hip
  Hybrid (compared to uncemented) [8] 1.6 1.40-1.80 < 0.001 Hip
Operative duration
  Length of operation (> 115 min) [23] 3.38 1.23-9.28 0.018 Hip
  (> 210 min) [14] 1.78 1.40-2.26 < 0.0001 Hip
  (≥ 240 min) [5] 2.7 1.50- 5.00 0.002 Hip/knee
Hospital factors
  Hospital volume < 100 (vs > 200/yr) [20] 0.33 0.12-0.90 0.03 Knee
  Medicare buy-in [14] 1.34 0.005 Hip
Table 5  Post-surgical risk factors
Ref. Statistical parameter Site
HR OR 95%CI P  value
Anaesthetic factors
  Intensive care length of stay (d) [15] 0.5 0.20-1.00 0.06 Knee
Haematological
  Blood transfusion [12] 2.11 1.10-3.90 0.02 Hip/knee
[15] 2.1 1.00-4.20 0.04 Hip/knee
[11] 1.63 1.14-2.33 0.007 Hip/knee
  Transfusion if RBCs stored > 14 d [24] 5.9 2.60-13.20 < 0.001 Knee
  Perioperative blood loss (via drain tube) [15] 1 1.00-1.01 0.008 Hip
Cardiac
  Postoperative atrial fibrillation [12] 6.22 1.40-28.5 0.02 Hip/knee
  Postoperative myocardial infarction [12] 20.4 2.10-199.9 0.009 Hip/knee
Hospital factors
  Longer hospital stay [12] 1.09 1.00-1.10 0.0003 Hip/knee
  Non same-day surgery [23] 4.16 1.44-12.02 0.008 Hip
Wound complications
  All wound complications [11] 27 11.00-91.6 0.0002 Hip/knee
  Wound discharge [5] 18.7 7.40-47.2 < 0.001 Hip/knee
[15] 6.3 1.30-30.7 0.02 Knee
[15] 5.4 2.00-15.0 0.001 Hip
[15] 5.7 2.40-13.3 <0.001 Hip/knee
[11] 32.2 8.7-119.17 < 0.0001 Hip/knee
  Haematoma [5] 3.5 1.30-9.50 0.01 Hip/knee
  Surgical site infection [1] 35.9 8.30-154.6 < 0.01 Hip/knee
  Superficial incisional SSI [15] 3.7 1.10-11.9 0.03 Knee
[15] 5 1.60-15.9 0.007 Hip
[15] 4.3 1.90 - 9.90 0.001 Hip/knee
  NNIS risk index 2 [9] 3.9 2.00-7.50 < 0.01 Hip/knee
Urinary
  Postoperative urinary infection [12] 5.45 1.00-8.70 0.04 Hip/Knee
[5] 2.7 1.04-7.10 0.04 Hip/Knee
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post­operative infection following lower limb arthroplasty. 
Multiple prospective and retrospective studies have 
reviewed the risks associated with their patient cohort 
developing such infections. This paper was undertaken 
to combine these risks and determine if there was a 
consensus to which factors puts a patient at highest risk, 
and categorise them if they related directly to the host 
(patient), provider (the surgical team and their Institute), 
or occurred during the post­operative period.
Little is known about the interaction between, or 
synergistic effect, of specific patient risk factors[35], as it is 
likely they have a multiplicity effect, rather than additive 
risk, as shown by Tomás[6]. In their cohort if a patient 
had two (or more) significant factors the probability of 
infection development was 14­times higher, whereas 
having three (or more) factors the probability was 
increased 16­times. 
Several themes have emerged following this syste­
matic review of the literature, specifically the patient’s 
immunological and systematic responses to infection, 
other sources of infection, antibiotic use, and provider 
factors.
Immunological response
The most frequently quoted risk factor was diabetes 
mellitus[4,9,17,20,22,26], which had one of the highest odds 
ratios[26]. Almost all the other highest odds ratio, or hazard 
ratio, also belonged to medical conditions ultimately 
impairing a patients immunity, as demonstrated from high 
dose pre­operative steroids[21], malnutrition (reflective 
of high alcohol intake[26], BMI below 20[21] and above 
50[13]), and tobacco use[23]. Malignancy[4,5], rheumatoid 
arthritis[4,15,16], and liver cirrhosis[28] can also impair a 
patient’s immunity.
Immunosuppression has long been known to increase 
a patient’s risk of systemic infection, and has widely 
been documented in arthroplasty patients. Ragni et al[36] 
demonstrated this in human immunodeficiency virus­
positive hemophiliacs with CD4 counts of 200 mm3 or less 
undergoing orthopaedic surgery. Post­operative infection 
occurred in 10 (15.1%) of 66 patients[36]. Local steroid 
injection causing focal immunosuppression about the 
joint has also been shown to increase the risk, compared 
to those that have not received any joint injections in hip 
arthroplasty cases[37]. 
In rheumatoid patients treated with immunosup­
pressive drugs (including biologic agents) undergoing all 
orthopeadic procedures, a statistically significant higher 
risk of infection was seen in this patient cohort compared 
to a degenerative/post­traumatic group (OR = 2.58, 
95%CI: 1.91­3.48, p < 0.001)[38]. Furthermore this risk 
was significantly increased in patients taking multiple 
disease­modifying antirheumatic drugs (DMARDs) (p = 
0.036) or tumor necrosis factor α (TNFα) inhibitors (p = 
0.032), especially if the last dose of TNFα inhibitor was 
given < 1 administration interval before surgery[38].
Infection response
While not directed specifically to immunosuppression, 
other co­morbidities have a role in reducing the patients 
systemic response to infection. Cardiac dysfunction[4,16,21], 
renal failure[4,15], anaemia[4,9,16] and coagulopathy[16] have 
all been shown to increase the risk of infection. This may 
be directed through specific cellular pathways[39], but 
may demonstrate the insult the surgical procedures has 
in causing a secondary inflammatory insults, worsening 
multiple organ dysfunction[40,41].
Deranges in renal function, with progressively higher 
poor glomerular filtration rate (GFR) in either the acute or 
chronic stages, reduces the ability to remove unwanted 
and hazardous chemicals from the blood, and places the 
patient at a higher risk. Lieberman et al[42] demonstrated 
Table 6  Classification of risk factors and probability of infection (main factors)
 Risk factor Minimum increase Maximum increase Statistical parameter Ref.
Host-related risk factors
  Modifiable Systemic steroids 3.3 21 OR [15,21]
Tobacco use 3.4 12.76 OR [23,32]
Nasal MRSA infection - 8.24 OR [31]
BMI < 20 - 6 OR [21]
Coronary artery disease - 5.1 OR [21]
COPD 1.22 4.34 OR [4,31]
BMI > 40 - 4.13 OR [23]
Pre-operative BM - 2.25 [17]
  Non-modifiable Diabetes 1.4 5.47 OR [15,26]
Liver cirrhosis - 5.4 HR [28]
Male 1.89 3.55 HR,OR [20,31]
Age - 3.36 OR [26]
Rheumatoid arthritis 1.18 3.3 OR [4,15]
Malignancy - 3.1 OR [5]
Provider-related risk factors
  Modifiable Quadriceps release (TKR) - 4.76 HR [20]
Non-same day procedure - 4.16 OR [23]
Prolonged operation 1.78 3.38 HR [14,23]
  Non-modifiable Prolonged storage of blood 2.6 13.2 OR [24]
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a high rates of infection in patients on chronic renal 
dialysis (19%), however in a separate patient series no 
significant increase in infection risk was seen[43].
Infection source
We believe that if a patient is known to have systemic 
infection, or a localised infection but distant to the operative 
joint, the risk of haematological spread of infection to the 
implant is highly likely. We have demonstrated a statistically 
significant increased risk of PJI in patients with a pre­
operative confirmation of a genitourinary infection[10,27], 
nasal S. Aureus and MRSA infections[31], or other distant 
organ infections[6], such as hepatitis B[44]. 
Conditions that further increase this risk are those 
that may make the patient more susceptible for the 
introduction of a new pathogen, such as chronic pulm­
onary disease[4,31] with known high rates of pneumonia, 
peripheral vascular disease[4,16] with high risk of skin 
ulceration and introduction of skin contaminates, and 
recent oesophagogastroduodenoscopy (EGD) with bio­
psy[22], risking the introduction of gut flora to the blood 
system.
Furthermore, perioperative blood transfusion increases 
the risk of PJI in both hip and knee arthroplasty[11,12,15], and 
allogeneic blood transfusion has been shown to instigate 
a detrimental immunomodulation reaction, and decreases 
T­cell­mediated immunity, and may enhance the acute 
inflammatory response[45,46]. Stored blood can cause a 
significant increase in inflammatory cytokine release from 
the stored neutrophils, and superoxide release results in 
delaying neutrophil apoptosis and risks cytotoxicity[47,48].
This has been confirmed in a recent systematic meta-
analysis of 6 studies demonstrating the association 
between allogeneic blood transfusion and an increased 
risk for a SSI after total hip and knee arthroplasty. Data 
was included from over 20000 patients, and the blood 
transfusion group had a significantly higher frequency 
of infection (pooled OR = 1.71, 95%CI: 1.23­2.40, p = 
0.002) compared to the non­exposed group[49].
Antibiotic use
The use of antibiotic­impregnated cement was shown by 
Dale et al[18] to protect against revisions due to infection, 
whereas Namba et al[20] identified an increased risk. 
Such conflicting outcomes are common in the literature 
regarding the use of antibiotic­impregnated cement in 
primary procedures. A prospective randomized study 
with 2948 cemented total knee arthroplasties failed to 
see an improvement of PJI rates by using bone cement 
loaded with erythromycin and colistin compared to 
controls[50], whereas the Norwegian Arthroplasty Register 
has demonstrated a synergistic effect of systemic 
and cement antibiotics[51]. However there is a general 
consensus that antibiotic­impregnated cement has a 
greater role in revision cases[52], and is recommended as 
standard practice in these high­risk cases[53].
Systemic antibiotics given at anaesthetic induction 
are generally the standard of care, and continued 
post­operatively for a further two doses in the United 
Kingdom, and for two days in Italy (authors experience). 
The choice of antibiotic varies in each Institute to reflect 
the prominent pathogen and patient cohort. Multiple 
studies have demonstrated the benefits of antibiotics 
given during the procedure to reduce the risk of post­
operative infection[51,54].
Provider factors
Concerning the relative impact of the hospitals yearly 
volume of procedures, we found only one retrospective 
review of joint registry data, that suggests that the 
fewer total knee arthroplasties undertaken per year 
will result in a lower rate of infection[20]. This particular 
finding needs, in our opinion, further validation, since it 
contradicts other reports demonstrating better outcomes 
from greater volumes of surgery and greater experience 
of the surgeons, as exemplified by the Hospital for 
Special Surgery, New York[55], while other studies have 
shown no difference between the two[56].
Furthermore, the use of a drain post­operatively 
has been shown by Peel et al[15] to reduce the risk of 
PJI following knee arthroplasty, however multiple meta­
analyses and prospective, randomised, controlled trials 
have demonstrated no significant difference in post­
operative infections between the wounds treated with a 
drain and those without[57,58].
Modifiable risk factors
When the risk factors were further categorised into 
modifiable or not, the vast majority of factors were non-
modifiable. Many risk factors increased a patient’s risk by 
less than 5 times (OR < 5), and very few increased the 
risk by more than 10 times.
However, the presence of non-modifiable risk factors 
still requires attention, and may be more important 
than modifiable ones. Alternate methods should be 
adopted to reduce the patient’s burden and may include 
a combination of implant modifications (such as silver 
or disposable microbiological coatings)[59,60], antibiotic 
impregnated cement or bone graft[61,62], or other novel 
therapies[63] to provide a personalized and more effective 
prophylaxis.
It is the responsibility of the operating team to act 
upon these, and modify or optimise the patient prior 
to surgery. For example, intensive insulin therapy, 
maintaining tight blood glucose concentrations between 
80 and 110 mg/dL, has been shown to decrease infection­
related complications and mortality[64]. Normal renal 
function should be sought, nutrition improved, cardiac 
investigations and interventions should be offered, local 
and systemic infections appropriately treated, as should 
chronic anaemia, and patients should be informed to 
withhold DMARDs and stop tobacco smoking and alcohol 
use preoperatively.
Risk-analysis tools 
Indeed, determining individual patients risks is an im­
portant step in personalized informed consent. Surgeons 
may quote published rates or their own, but the risk 
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is individual and should reflect all the aforementioned 
factors, which may have consequences in the medico­
legal evaluation in case of damage evaluation after PJI.
Previous attempts to combine such measures in 
a scoring system have been attempted by The Mayo 
Clinic[65] who based the data on their cohort of patients 
at baseline and at one month. Bozic et al[35] developed 
a risk calculator using data from 11 years worth of 
Medicare claims. A similar tool has been developed in the 
Chinese population[26].
The main disadvantage of such tools is the cal­
culations relate to a specific set of patients, and may not 
reflect the general public risks, as they have not been 
externally validated. In addition the data is unlikely to 
appreciate advances in perioperative care over the time 
period, and may not capture patients with late onset PJI 
if follow­up is short. 
Limitations
A wide variety of studies were included in this systematic 
review, which gives an overview of risk factors for hip 
and knee PJI but the quality of each study is generally 
poor. As previously discussed, only 8 studies (29.6%) 
were prospective, and one third of studies demonstrated 
record bias. Reporting bias was also seen amongst the 
studies, as a variety of diagnostic criteria were used. This 
is common amongst studies reviewing PJI as there is 
no gold standard measure to determine presence of 
infection, nor an agreement to the medical, or surgical 
management, for these patients[53]. 
Our search criteria only highlighted studies with “risk 
factor” in the title, and therefore we did not search for 
studies looking at individual risk factors. Therefore studies, 
some of high quality, may not have met our inclusion 
criteria. Furthermore, we were unable to undertake a meta­
analysis due to the heterogeneity of the data.
In conclusion, as demonstrated, current data is 
conflicting as the influence of the risk factors vary widely, 
and we believe more emphasis is required regarding the 
multiplicity effects of risk factors. We need larger studies 
and novel tools to investigate single and combined risk 
factors, and to identify key areas of improvement and 
modification for these patients. 
The literature has demonstrated significant variation 
in the number and type of risk factors that places a 
patient at higher risk of developing a PJI, which is heavily 
weighted towards the patient. However the provider 
has a role in addressing the modifiable risk factors pre-
operatively to optimise their patient, and develop new 
strategies to limit the impact of non-modifiable factors.
coMMEntS
Background
Several studies have previously shown the impact of various risk factors on the 
probability of developing an infection after joint replacement. The heterogeneity of 
the available data notwithstanding, in this systematic review a detailed analysis of 
the respective weight of known risk factors, classified as host-, provider- or post-
surgical-related, is performed; moreover, a further distinction in modifiable or not-
modifiable risk factors is proposed. 
Research frontiers
A classification and ranking of known risk factors may open new frontiers 
in prevention and control of peri-prosthetic infections. Furthermore, it can 
be helpful to improve the information to the patient prior to surgery, to drive 
personalised prophylaxis and to better evaluate the cost-to-benefit ratio of new 
technologies, like antibacterial coatings, designed to reduce bacterial adhesion 
on implanted biomaterials.
Innovations and breakthrough
This systematic review sheds new lights on the relative impact of various risk 
factors that increase a patient’s risk of developing lower limb periprosthetic 
joint infections (PJI). This ultimately reiterates the importance of optimising the 
patients pre-operatively by addressing modifiable risk factors (such as their 
immunosuppression, nutrition, diabetes, and smoking), and develops strategies 
to limit the impact of non-modifiable factors.
Applications
The data obtained in this systematic review may form the basis for the development 
of specific software, like the “PJI Risk App”, an application for smartphones, 
specifically designed to calculate the risk of developing a peri-prosthetic infection 
in a given patient. This in turn may be useful for surgeons and their patients to 
understand the specific risk of undergoing joint replacement and eventually to better 
tailor antibiotic prophylaxis.  
Peer-review 
In this manuscript authors reviewed provider risk factors of chronic PJI. This 
study is interesting and the objective very clear.
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